SCHEDULE: Dimensional Fund Advisors Reports 5.1% Stake in Avanos Medical
Beneficial Ownership Report
Dimensional Fund Advisors LP has filed an amended Schedule 13G, disclosing a 5.1% beneficial ownership stake in Avanos Medical Inc.
Summary
- Dimensional Fund Advisors LP, an investment adviser, reported beneficial ownership of 2,352,634 shares of Avanos Medical Inc. common stock.
- This ownership represents 5.1% of the class of securities.
- Dimensional Fund Advisors LP holds sole voting power over 2,282,916 shares and sole dispositive power over 2,352,634 shares.
- The shares are owned by various funds advised by Dimensional, which disclaims beneficial ownership of these securities.
- The filing is an Amendment No. 2 to a previous Schedule 13G statement.
Sentiment
Score: 7
Explanation: The filing reports a significant and continued institutional ownership stake by a reputable investment adviser, which is generally viewed as a positive signal of confidence in the company's long-term prospects.
Positives
- A significant institutional investor, Dimensional Fund Advisors LP, maintains a substantial stake (5.1%) in Avanos Medical Inc., indicating continued confidence in the company.
- The investment is held in the ordinary course of business and not for the purpose of influencing control, suggesting a long-term, passive investment strategy.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- Dimensional Fund Advisors LP certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of Avanos Medical Inc.
Industry Context
The filing indicates continued institutional interest in Avanos Medical Inc., a company operating in the medical device and healthcare sector. Large institutional holdings by firms like Dimensional Fund Advisors are common and often viewed as a sign of stability and long-term investment potential within the industry.
Stakeholder Impact
- Shareholders may view the continued significant stake by Dimensional Fund Advisors LP as a positive indicator of the company's value and stability, potentially bolstering investor confidence.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring this filing |
| 10/09/2025 | Date of filing signature |
Recommendation
holdThe filing confirms a substantial and ongoing institutional ownership by Dimensional Fund Advisors LP, a respected investment firm. While this alone doesn't provide new fundamental insights for a 'buy' or 'sell' decision, it signals continued institutional confidence in Avanos Medical. For investors, this suggests the stock meets the criteria of a systematic, long-term investor, making a 'hold' recommendation appropriate for those who align with such institutional backing, pending further fundamental analysis.
Keywords
Avanos Medical Inc, Dimensional Fund Advisors, Institutional Ownership, Common Stock, Medical Devices, Healthcare, Investment Adviser, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.